Our mission is to treat patients suffering from primary immunodeficiency diseases with hematopoietic stem cell gene therapy.🩸🦠✂️🧬⛑: tweets from lab members.
Westwood, Los Angeles
Joined September 2020
- Tweets233
- Following103
- Followers532
- Likes258
This week, the Kohn lab is coming to New Orleans for #ASGCT2025 ! Another special year for us because our PI is this year’s @ASGCTherapy Founders Award recipient. Don’t miss the Founder’s Keynote tomorrow afternoon! Look out for the 👨🏻#genetherapy #PIDD #raredisease
Annual ASGCT Kohn lab (past and present) dinner. It's always great catching up with previous members. Hearing their success stories and how they're leading their own group inspires to us even more to be great in this field. #ASGCT2024
5th yr PhD candidate, Eva Segura, presenting our progress on lentivirus-based gene therapy for Alpha-Thalassemia. ##ASGCT2024
@C_Luthers31 presents his work where he is investigating our site-specific gene integration strategy on X-linked agammaglobulinemia (XLA) using a murine XLA-disease model. #ASGCT2024
Every year @ASGCTherapy reminds us how blessed we are to be under Dr. Donald B. Kohn’s mentorship. 🩸🧬🦠 ✂️ #ASGCT2024
Baltimore here we come! We're excted to see everyone again & learn more science at #ASGCT2024. We invite you to stop by on Thursday where Christopher Luthers (4th PhD candidate) will share our progress on developing a gene editing strategy for X-linked agammaglobulinemia (XLA).🧬
An early celebration for our lab before the holidays as our senior graduate student defends his PhD thesis. Congrats to our soon to be Dr. @PaulAyoubG 🥂 #genetherapy
Let’s Talk Science. Learn more about UCLA’s progress in bridging the gap between basic and translational research. This seminar will focus on the journey from moving research from bench and bedside. Today @ 5:30-630 pm PST. ucla.zoom.us/webinar/registe…
3rd year Phd Candidate Christopher Luthers is here to discuss our gene editing strategy to develop a long-term cure for X-linked Agammaglobulinemia (XLA), an immune disorder that causes the inability to produce mature B cells which results in low levels of antibody production.
Today at @UCLATDG ‘s annual LA Bioscience Summit (#LABEST2023), A panel of academic researchers focused on regenerative medicine (including our own Dr. Donald B Kohn) are discussing their experiences in moving their research from bench to benchside.
PhD candidate, Eva Segura, presenting her project during the lightning round at the 2nd Annual Ginsburg Symposium: Frontiers in Pediatric Precision Health. #UCLA #GeneTherapy
Catch Poster #1194 on the 3rd day of #ASGCT2023. PhD candidate @PaulAyoubG will be presenting the development of our Lentiviral Vectors with Regulated Expression to Treat X-Linked Lymphoproliferative Disease” #GeneTherapy #XLP #RareDisease
Catch Poster #630 on the second day of #ASGCT2023. 4th yr PhD candidate Eva Segura Gensler is here to present our work on “Alpha Globin Lentiviral Vectors for Hematopoietic Stem Cell Gene Therapy of Alpha-Thalassemia” #GeneTherapy
